Complete question:
Receptors trigger one of two effector pathways resulting in changes in neuronal activity. These changes will, ultimately, effect gene expression. Which effector pathway is characterized by ion flux through transmitter-activated channels resulting in an altered membrane potential and neuronal activity?
A. Slow effector pathways
B. Modulated effector pathways
C. Rapid effector pathways
D. NMDA glutamate receptor pathways
Answer:
D. NMDA glutamate receptor pathways
Explanation:
The NMDA glutamatergic receptor is a cationic channel receptor modulated by a ligand that allows the transport of Na+, K+, and Ca2+. Under certain situations, it exhibits particular permeability to Ca2+. The receptor has different regions that are susceptible to modulation by endogenous and exogenous agents. The receptor can be found at most excitatory synapses, where it responds to the neurotransmitter glutamate. During synapsis, the presynaptic membrane releases L-glutamate, which is received by NMDA glutamatergic receptor. The receptor plays a regulatory role because activates signaling cascades that depend on calcium.
These receptors are involved in normal synaptic transmission, in a diverse physiological phenomenon, and might be responsible for neurodegenerative processes.
I hope this helps you very much you’re welcome !
The smaller a population, the greater the potential effect of genetic drift on gene frequencies.
Genetic drift is an evolutionary term which refers to the random changes in a population's allele frequencies. These changes happen by chance due to the random selection of alleles from the genetic pool in each generation. Genetic drift can lead to either loss of some alleles or the fixation of others (100% frequency). The effect of genetic drift is stronger in smaller populations. This is because, the larger the population, the larger the sample size and the slower the result of genetic drift.
Answer:
Other important ethical issues relate to informed consent of both donors of gametes and embryos as well as recipients of stem cells and stem cell products. Further, there has been some concern related to the commercialization of the process, justice, and the responsible conduct of research.
Explanation: